Membrane fusion: A new function of non steroidal anti-inflammatory drugs

Biophysical Chemistry

Volumn 137, Issue 1, 2008, Pages 28-34

  Chakraborty, Hirak ^a   Mondal, Sutapa ^a   Sarkar, Munna ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Content mixing; Fluorescence spectroscopy; NSAIDs; Small Unilamellar Vesicles (SUVs); Transmission electron microscopy (TEM)

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPICOLINIC ACID; IBUPROFEN; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID; PIROXICAM; PROPIONIC ACID DERIVATIVE; TENOXICAM; TERBIUM;

ARTICLE; ARTIFICIAL MEMBRANE; FLUORESCENCE SPECTROSCOPY; MEMBRANE FUSION; MEMBRANE VESICLE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; IBUPROFEN; INDOMETHACIN; MEMBRANE FUSION; PIROXICAM; PROPIONIC ACIDS; THIAZINES; THIAZOLES;

EID: 48849113291     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2008.06.007     Document Type: Article

References (38)

1. Sporn M.B., and Suh N. Chemoprevention of cancer, Carcinogenesis 21 (2000) 525-530
2. Ritland S.R., and Gendler S.J. Chemoprevention of intestinal adenomas in the APCmin mouse by piroxicam: kinetics, strain effects and resistance to chemoprevention. Carcinogenesis 20 (1999) 51-58
3. Grossman E.M., Longo W.E., Panesar N., Mazuski J.E., and Kaminshi D.L. The role of cyclooxygenase enzyme in the growth of human gall bladder cancer cells. Carcinogenesis 21 (2000) 1403-1409
4. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterlingk N., Golde T.E., and Koo E.H. A subset of NSAIDs lower amyloidogenic A42 independently of cyclooxygenase activity. Nature 414 (2001) 212-215
5. Hoozemans J.J.M., Veerhuis R., Janssen I., Elk E.V., Rozemuller A.J.M., and Eikelenboom P. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: Implications for Alzheimer's disease. Brain Res, 951 (2002) 218-226
6. Sagi S.A., Weggen S., Eriksen J., Golde T.E., and Koo E.H. The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of B kinase, and NFB, do not reduce amyloid 42 production. J. Biol. Chem. 278 (2003) 31825-31830
7. Chakraborty H., Chakraborty P.K., Raha S., Mandal P.C., and Sarkar M. Interaction of piroxicam with mitochondrial membrane and cytochrome c. BBA Biomembranes 1768 (2007) 1138-1146
8. Roy S., Banerjee R., and Sarkar M. Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone. J. Inorg. Biochem. 100 (2006) 1320-1331
9. Gerst J.E. SNAREs and SNARE regulators in membrane fusion and exocytosis. Cell. Mol. Life Sci. 55 (1999) 707-734
10. Hernandez L.D., Hoffman L.R., Wolfsberg T.G., and White J.M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12 (1996) 627-661
11. Ulrich A.S., Otter M., Glabe C.G., and Hoekstra D. Membrane fusion is induced by a distinct peptide sequence of the sea urchin fertilization protein bindin. J. Biol. Chem. 273 (1998) 16748-16755
12. Rothman J.E., and Wieland F.T. Protein Sorting by Transport Vesicles. Science 272 (1986) 227-234
13. Jahn R., Lang T., and Sudhof T.C. Membrane fusion. Cell 112 (2003) 519-533
14. Leikina E., Markovic I., Chernomordik L.V., and Kozlov M.M. Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis. Biophys. J. 79 (2000) 1415-1427
15. Haque M.E., Koppaka V., Axelsen P.H., and Lentz B.R. Properties and Structures of the Influenza and HIV Fusion Peptides on Lipid Membranes: Implications for a Role in Fusion. Biophys. J. 89 (2005) 3183-3194
16. Lentz B.R., Talbot W., Lee J., and Zheng L.-X. Transbilayer lipid redistribution accompanies poly(ethylene glycol) treatment of model membranes but is not induced by fusion. Biochemistry 36 (1997) 2076-2083
17. Fernandez I., Araç D., Ubach J., Gerber S.H., Shin O.-H., Gao Y., Anderson R.G.W., Südhof T.C., and Rizo J. Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid-binding machine. Neuron 32 (2001) 1057-1069
18. Zimmerberg J., and Chernomordik L.V. Membrane fusion. Adv. Drug Deliv. Rev. 38 (1999) 197-205
19. Kemble G.W., Danieli T., and White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76 (1994) 383-391
20. Lee J., and Lentz B.R. Evolution of lipidic structure during model membrane fusion and the relation of this process to cell membrane fusion. Biochemistry 36 (1997) 6251-6259
21. Fernandez J.M., Neher E., and Gomperts B.D. Capacitance measurements reveal stepwise fusion events in degranulating mast cells. Nature 312 (1984) 453-455
22. Chanturiya A., Chernomordik L.V., and Zimmerberg J. Flickering fusion pores comparable with initial exocytotic pores occurs in protein-free phospholipid bilayer. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14423-14428
23. Swift J.L., Carnini A., Dahms T.E.S., and Cramb D.T. Anesthetic-enhanced membrane fusion examined using two-photon fluorescence correlation spectroscopy. J. Phys. Chem. B 108 (2004) 11133-11138
24. Fox C.B., Horton R.A., and Harris J.M. Detection of drug-membrane interactions in individual phospholipid vesicles by confocal Raman microscopy. Anal. Chem. 78 14 (2006) 4918-4924
25. Hwang S.-B., and Shen T.Y. Membrane effects of antiinflammatory agents. 2. Interaction of nonsteroidal antiinflammatory drugs with liposome and purple membranes. J. Med. Chem. 24 (1981) 1202-1211
26. Chakraborty H., Roy S., and Sarkar M. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs. Chem. Phys. Lipids 138 (2005) 20-28
27. Huang C.H. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry 8 (1969) 344-352
28. Fiske C.H., and Subbarow Y. The calorimetric determination of phosphorous. J. Biol. Chem. 66 (1925) 375-400
29. Wilschut J., Duzgunes N., Fraley R., and Papahadjopoulos D. Studies on the mechanism of membrane fusion: kinetics of calcium ion induced fusion of phosphatidylserine vesicles followed by a new assay for mixing of aqueous vesicle contents. Biochemistry 19 (1980) 6011-6021
30. Duzgunes N., and Wilschut J. Fusion assays monitoring intermixing of aqueous contents. In: Duzgunes N. (Ed). Methods in Enzymology vol. 220 (1993), Academic Press, Inc., San Diego 3-14
31. Haque M.E., and Lentz B.R. Influence of gp41 fusion peptide on the kinetics of poly(ethylene glycol)-mediated model membrane fusion. Biochemistry 41 (2002) 10866-10876
32. Takeda Y., and Kasamo K. In vitro fusion of plant golgi membranes can be influenced by divalent cations. J. Biol. Chem. 27 (2002) 47756-47764
33. 2B-domain: Synaptotagmin 1 as a phospholipid binding machine. Neuron 32 (2001) 1057-1070
34. Chernomordik L., Kozlov M.M., and Zimmerberg J. Lipids in Biological Membrane Fusion. J. Membrane Biol. 146 (1995) 1-14
35. Markin V.S., Kozlov M.M., and Borovjagin V.L. On the theory of membrane fusion: The stalk mechanism. Gen. Physiol. Biophys. 3 (1984) 361-377
36. Kuzmin P.I., Zimmerberg J., Chizmadzhev Y.A., and Cohen F.S.A. Quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7235-7240
37. Broder C.C., and Dimitrov D.S. HIV and the 7-transmembrane domain receptor. Pathobiology 64 (1996) 171-179
38. Nieva J.L., Nir S., Muga A., Goni F.M., and Wilschut J. Interaction of the HIV-I fusion peptide with phospholipid vesicles: different structural requirement for fusion and leakage. Biochemistry 33 (1994) 3201-3209